Purchase Order 75N95024P00468
- Not listed
- This is a firm-fixed-price purchase order contract awarded by the National Institute on Aging (NIA), a civilian federal agency, to the National University of Singapore (NUS) for $149,450.40. The contract is for testing the efficacy of candidate Alzheimer's disease treatments in rescuing impaired hippocampal synaptic plasticity. The contract does not have a set-aside designation. NUS is an international research institution with extensive expertise in advanced scientific research, including...
- This is a firm fixed-price purchase order awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute on Aging to the National University of Singapore. The $169,830 contract is for testing the efficacy of candidate Alzheimer's disease treatments in rescuing impaired hippocampal synaptic plasticity. This is part of the NIH's Drug Repurposing for Effective Alzheimer's Medicines (DREAM) study, which is testing approximately 20 FDA-approved drugs to...
- This is a firm-fixed price purchase order contract awarded by the National Institutes of Health (NIH), which is part of the U.S. Department of Health and Human Services (DHHS), to the National University of Singapore. The contract is for $105,750.00 to provide tissue sample and medical record preparation services in support of the SHERLOCK-LUNG study on never-smoking lung cancer cases in Singapore. This research supports the NIH's work in studying lung cancer. The National University of...
- This federal contract award is for a Dengue Biomarker Study for the Naval Medical Research Center Asia (NMRC-Asia), with a ceiling value of $80,000.00. The contract was awarded to the National University of Singapore (NUS), a leading global university in Asia that has a history of collaborating with U.S. government agencies on research and development projects. The contract is a firm-fixed price BPA call, with no set-aside designation. NUS has received numerous federal contract awards and...
- This is a $199,812 firm fixed price purchase order awarded by the National Institutes of Health's (NIH) National Institute on Aging (NIA) to QPS Austria GMBH, a contract research organization. The contract is for in vivo efficacy studies of a candidate Alzheimer's treatment in a transgenic mouse model. This award is part of the NIA's Drug Repurposing for Effective Alzheimer's Medicines (DREAM) study, which aims to identify FDA-approved drugs that may be repurposed as disease-modifying...
- <p>The National Institute on Aging, a civilian federal agency, awarded a $17,500.00 Firm Fixed Price Purchase Order to Alamar Biosciences, Inc. to provide laboratory and testing services for the NULISASEQ CNS Disease Panel service. The award has an ultimate completion date of August 11, 2024. The contract does not have a set-aside designation.</p>
- The Department of Health and Human Services' National Institutes of Health National Institute on Aging has awarded a $830,053.00 firm fixed price delivery order contract to QPS Austria GMBH, a contract research organization, to conduct experimental validation of candidate Alzheimer's disease treatments identified through multi-omics analyses. This delivery order is part of a larger indefinite delivery contract with QPS Austria GMBH to provide these services, with a potential total value...
- This is a firm fixed price contract awarded by the Department of the Navy Bureau of Medicine and Surgery to the National University of Singapore, a non-profit research organization, to provide contractor support services for a NMRC-A zooprophylaxis aided ivermectin-based vector elimination project in Vietnam. The contract has a potential value of $145,092.00 and a completion date of September 14, 2018. The contract does not have a set-aside designation. The National University of Singapore has...
- The Department of Health and Human Services' National Institutes of Health National Institute on Aging awarded a $298,624 firm fixed-price purchase order to QPS Austria GmbH to provide phenotypic screening services to identify effective treatments for Alzheimer's disease. The requirement, as outlined in the solicitation, is for the contractor to test approximately 20 FDA-approved drugs that have been nominated as potential treatments in order to determine if exposure is associated with lower...
- This is a firm fixed-price delivery order contract awarded by the National Institute on Aging (NIA), a civilian federal agency, to Scantox Neuro GMBH, a for-profit organization based in Austria. The contract, valued at $858,106.08, is for the experimental validation of candidate Alzheimer's disease treatments identified through multi-omics analyses. This work supports ongoing NIA research initiatives such as the Drug Repurposing for Effective Alzheimer's Medicines (DREAM) and PREVENT-AD studies....
This is a firm-fixed price purchase order awarded by the National Institute on Aging, a civilian federal agency, to the National University of Singapore (NUS) for $37,362.60. The contract is for testing the efficacy of novel candidate Alzheimer's disease drugs in rescuing impaired hippocampal synaptic plasticity in the APP/PS1 transgenic mouse model. The award does not utilize any set-aside designations, reflecting NUS's competitive capabilities as an international research institution. NUS has extensive expertise in advanced scientific research across various disciplines and has executed numerous federal contracts and grants with agencies such as the Department of Defense and USAID, often in partnership with prestigious U.S. research institutions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Terminate for Convenience | $0 | 4/30/25 | |
| Not listed | Not listed | $37.4k | 8/21/24 |